New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Study links periodontal bacteria to worsening rheumatoid arthritis September 5, 2024 Groundbreaking joint statement issued on the development and use of AI tools in radiology January 25, 2024 High-impact clinical trial results to be presented at ASN Kidney Week 2023 November 3, 2023
Groundbreaking joint statement issued on the development and use of AI tools in radiology January 25, 2024